Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
308,713,740
-
Number of holders
-
130
-
Total 13F shares, excl. options
-
156,858,667
-
Shares change
-
+8,003,285
-
Total reported value, excl. options
-
$779,548,508
-
Value change
-
+$23,503,784
-
Put/Call ratio
-
24.51%
-
Number of buys
-
77
-
Number of sells
-
-59
-
Price
-
$4.97
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q4 2016
179 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock as of Q4 2016.
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) has 130 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 156,858,667 shares
of 308,713,740 outstanding shares and own 50.81% of the company stock.
Largest 10 shareholders include FMR LLC (21,348,929 shares), PERCEPTIVE ADVISORS LLC (17,296,672 shares), Redmile Group, LLC (12,331,130 shares), JENNISON ASSOCIATES LLC (9,277,910 shares), VANGUARD GROUP INC (8,333,811 shares), BlackRock Fund Advisors (7,585,493 shares), JANUS CAPITAL MANAGEMENT LLC (6,891,791 shares), Palo Alto Investors, LLC (6,410,030 shares), STATE STREET CORP (5,715,947 shares), and Sectoral Asset Management Inc (5,100,198 shares).
This table shows the top 130 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.